BACE1 and Alzheimer disease: To the best our knowledge, it is the first attempt to design the discovery of multi-target inhibitors against BACE1, AChE, QC, and GSK3-3β in M. officinalis-derived compounds as the preventive and/or therapeutic strategy for AD.